Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17


Comparison of etomidate and sodium thiopental for induction during rapid sequence intubation in convulsive status epilepticus: A retrospective single-center study.

Perier F, Chateauneuf AL, Jacq G, Holleville M, Schnell D, Merceron S, Cavelot S, Richard O, Legriel S; ICTAL Study Group.

Seizure. 2018 Oct;61:170-176. doi: 10.1016/j.seizure.2018.08.022. Epub 2018 Aug 28.


Cardiac Arrest in Patients Managed for Convulsive Status Epilepticus: Characteristics, Predictors, and Outcome.

Legriel S, Bresson E, Deye N, Grimaldi D, Sauneuf B, Lesieur O, Lascarrou JB, Argaud L, Chelly J, Beuret P, Schnell D, Chateauneuf AL, Holleville M, Perier F, Lemiale V, Bruel C, Cronier P, Pichon N, Mongardon N, de-Prost N, Dumas F, Cariou A.

Crit Care Med. 2018 Aug;46(8):e751-e760. doi: 10.1097/CCM.0000000000003196.


Super-refractory status epilepticus: epidemiology, early predictors, and outcomes.

Chateauneuf AL, Moyer JD, Jacq G, Cavelot S, Bedos JP, Legriel S.

Intensive Care Med. 2017 Oct;43(10):1532-1534. doi: 10.1007/s00134-017-4837-6. Epub 2017 May 11. No abstract available.


Potent and selective 5-LO inhibitor bearing benzothiophene pharmacophore: discovery of MK-5286.

Li L, Berthelette C, Chateauneuf A, Ouellet M, Sturino CF, Wang Z.

Bioorg Med Chem Lett. 2010 Dec 15;20(24):7440-3. doi: 10.1016/j.bmcl.2010.10.024. Epub 2010 Oct 15.


The discovery of setileuton, a potent and selective 5-lipoxygenase inhibitor.

Ducharme Y, Blouin M, Brideau C, Châteauneuf A, Gareau Y, Grimm EL, Juteau H, Laliberté S, MacKay B, Massé F, Ouellet M, Salem M, Styhler A, Friesen RW.

ACS Med Chem Lett. 2010 Apr 13;1(4):170-4. doi: 10.1021/ml100029k. eCollection 2010 Jul 8.


2,3-Diarylthiophenes as selective EP1 receptor antagonists.

Ducharme Y, Blouin M, Carrière MC, Chateauneuf A, Côté B, Denis D, Frenette R, Greig G, Kargman S, Lamontagne S, Martins E, Nantel F, O'Neill G, Sawyer N, Metters KM, Friesen RW.

Bioorg Med Chem Lett. 2005 Feb 15;15(4):1155-60.


Structure-activity relationship of triaryl propionic acid analogues on the human EP3 prostanoid receptor.

Gallant M, Belley M, Carrière MC, Chateauneuf A, Denis D, Lachance N, Lamontagne S, Metters KM, Sawyer N, Slipetz D, Truchon JF, Labelle M.

Bioorg Med Chem Lett. 2003 Nov 3;13(21):3813-6.


Discovery of a potent and selective agonist of the prostaglandin EP4 receptor.

Billot X, Chateauneuf A, Chauret N, Denis D, Greig G, Mathieu MC, Metters KM, Slipetz DM, Young RN.

Bioorg Med Chem Lett. 2003 Mar 24;13(6):1129-32.


Molecular pharmacology of the human prostaglandin D2 receptor, CRTH2.

Sawyer N, Cauchon E, Chateauneuf A, Cruz RP, Nicholson DW, Metters KM, O'Neill GP, Gervais FG.

Br J Pharmacol. 2002 Dec;137(8):1163-72.


Structure-activity relationship of biaryl acylsulfonamide analogues on the human EP(3) prostanoid receptor.

Gallant M, Carrière MC, Chateauneuf A, Denis D, Gareau Y, Godbout C, Greig G, Juteau H, Lachance N, Lacombe P, Lamontagne S, Metters KM, Rochette C, Ruel R, Slipetz D, Sawyer N, Tremblay N, Labelle M.

Bioorg Med Chem Lett. 2002 Sep 16;12(18):2583-6.


Selective modulation of chemokinesis, degranulation, and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP.

Gervais FG, Cruz RP, Chateauneuf A, Gale S, Sawyer N, Nantel F, Metters KM, O'neill GP.

J Allergy Clin Immunol. 2001 Dec;108(6):982-8.


Coexpression of full-length gamma-aminobutyric acid(B) (GABA(B)) receptors with truncated receptors and metabotropic glutamate receptor 4 supports the GABA(B) heterodimer as the functional receptor.

Sullivan R, Chateauneuf A, Coulombe N, Kolakowski LF Jr, Johnson MP, Hebert TE, Ethier N, Belley M, Metters K, Abramovitz M, O'Neill GP, Ng GY.

J Pharmacol Exp Ther. 2000 May;293(2):460-7.


Characterization of the human cysteinyl leukotriene CysLT1 receptor.

Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, Coulombe N, Abramovitz M, Figueroa DJ, Zeng Z, Connolly BM, Bai C, Austin CP, Chateauneuf A, Stocco R, Greig GM, Kargman S, Hooks SB, Hosfield E, Williams DL Jr, Ford-Hutchinson AW, Caskey CT, Evans JF.

Nature. 1999 Jun 24;399(6738):789-93.


Cloning of a novel G-protein-coupled receptor GPR 51 resembling GABAB receptors expressed predominantly in nervous tissues and mapped proximal to the hereditary sensory neuropathy type 1 locus on chromosome 9.

Ng GY, McDonald T, Bonnert T, Rigby M, Heavens R, Whiting P, Chateauneuf A, Coulombe N, Kargman S, Caskey T, Evans J, O'neill GP, Liu Q.

Genomics. 1999 Mar 15;56(3):288-95.


Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity.

Ng GY, Clark J, Coulombe N, Ethier N, Hebert TE, Sullivan R, Kargman S, Chateauneuf A, Tsukamoto N, McDonald T, Whiting P, Mezey E, Johnson MP, Liu Q, Kolakowski LF Jr, Evans JF, Bonner TI, O'Neill GP.

J Biol Chem. 1999 Mar 19;274(12):7607-10.


Molecular characterization and expression of cloned human galanin receptors GALR2 and GALR3.

Kolakowski LF Jr, O'Neill GP, Howard AD, Broussard SR, Sullivan KA, Feighner SD, Sawzdargo M, Nguyen T, Kargman S, Shiao LL, Hreniuk DL, Tan CP, Evans J, Abramovitz M, Chateauneuf A, Coulombe N, Ng G, Johnson MP, Tharian A, Khoshbouei H, George SR, Smith RG, O'Dowd BF.

J Neurochem. 1998 Dec;71(6):2239-51.


A role for ultraviolet A in solar mutagenesis.

Drobetsky EA, Turcotte J, Châteauneuf A.

Proc Natl Acad Sci U S A. 1995 Mar 14;92(6):2350-4.

Supplemental Content

Loading ...
Support Center